Literature DB >> 23237697

OPTN/SRTR 2011 Annual Data Report: liver.

W R Kim1, P G Stock, J M Smith, J K Heimbach, M A Skeans, E B Edwards, A M Harper, J J Snyder, A K Israni, B L Kasiske.   

Abstract

The current liver allocation system, introduced in 2002, decreased the importance of waiting time for allocation priorities; the number of active wait-listed candidates and median waiting times were immediately reduced. However, the total number of adult wait-listed candidates has increased since 2002, and median waiting time has increased since 2006. Pretransplant mortality rates have been stable, but the number of candidates withdrawn from the list as being too sick to undergo transplant nearly doubled between 2009 and 2011. Deceased donation rates have remained stable, with an increasing proportion of expanded criteria donors. Living donation has decreased over the past 10 years. Transplant outcomes remain robust, with continuously improving graft survival rates for deceased donor, living donor, and donation after circulatory death livers. Numbers of new and prevalent pediatric candidates on the waiting list have decreased. Pediatric pretransplant mortality has decreased, most dramatically for candidates aged less than 1 year. The transplant rate has increased since 2002, and is highest in candidates aged less than 1 year. Graft survival continues to improve for pediatric recipients of deceased donor and living donor livers. Incidence of acute rejections increases with time after transplant. Posttransplant lymphoproliferative disorder remains an important concern in pediatric recipients. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23237697     DOI: 10.1111/ajt.12021

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  57 in total

1.  Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic.

Authors:  D S Goldberg; E Blumberg; M McCauley; P Abt; M Levine
Journal:  Am J Transplant       Date:  2016-08-24       Impact factor: 8.086

2.  Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.

Authors:  A U Engela; C C Baan; N H R Litjens; M Franquesa; M G H Betjes; W Weimar; M J Hoogduijn
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

3.  Liver transplantation for alcoholic liver disease: a devilish dilemma.

Authors:  Stephen E Congly; Samuel S Lee
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

4.  Who should undergo liver transplantation for hepatocellular carcinoma? Ablate, wait … and see!

Authors:  Willscott E Naugler; Barry Schlansky; Susan L Orloff
Journal:  Hepat Oncol       Date:  2014-03-20

5.  Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.

Authors:  Joseph Benton Oliver; Andrea Fleisch Marcus; Mark Paster; Joseph Nespral; Advaith Bongu; George Dikdan; Lloyd Brown; Nikole Neidlinger; Baburao Koneru
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

6.  Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.

Authors:  Fei Teng; Gui-Hua Wang; Yi-Feng Tao; Wen-Yuan Guo; Zheng-Xin Wang; Guo-Shan Ding; Xiao-Min Shi; Zhi-Ren Fu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 7.  Management of hepatitis C infection before and after liver transplantation.

Authors:  Stefano Fagiuoli; Roberto Ravasio; Maria Grazia Lucà; Anna Baldan; Silvia Pecere; Alessandro Vitale; Luisa Pasulo
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis.

Authors:  Gregory C Wilson; R Cutler Quillin; Koffi Wima; Jeffrey M Sutton; Richard S Hoehn; Dennis J Hanseman; Ian M Paquette; Flavio Paterno; E Steve Woodle; Daniel E Abbott; Shimul A Shah
Journal:  HPB (Oxford)       Date:  2014-08-06       Impact factor: 3.647

Review 9.  Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation.

Authors:  Stephen E Congly; Karen E Doucette; Carla S Coffin
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.

Authors:  Jennifer A Flemming; Parsia A Vagefi; Chris E Freise; Francis Y Yao; Norah A Terrault
Journal:  Liver Transpl       Date:  2014-09-03       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.